Search This Blog

Tuesday, November 27, 2018

Intellia Therapeutics initiated at Leerink


Intellia Therapeutics initiated with an Outperform at Leerink. Leerink analyst Mani Foroohar initiated Intellia Therapeutics with an Outperform rating and a price target of $23.
https://thefly.com/landingPageNews.php?id=2828749
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)